BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17082810)

  • 1. Mechanisms of disease: adrenocortical tumors--molecular advances and clinical perspectives.
    Bertherat J; Groussin L; Bertagna X
    Nat Clin Pract Endocrinol Metab; 2006 Nov; 2(11):632-41. PubMed ID: 17082810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Sporadic adrenocortical tumors: genetics and perspectives for the pathologist].
    Tissier F
    Ann Pathol; 2008 Oct; 28(5):409-16. PubMed ID: 19068395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of benign adrenocortical tumors.
    Vezzosi D; Bertherat J; Groussin L
    Best Pract Res Clin Endocrinol Metab; 2010 Dec; 24(6):893-905. PubMed ID: 21115158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New insights in the genetics of adrenocortical tumors, pheochromocytomas and paragangliomas.
    Bertherat J; Gimenez-Roqueplo AP
    Horm Metab Res; 2005 Jun; 37(6):384-90. PubMed ID: 16001332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutations of beta-catenin in adrenocortical tumors: activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors.
    Tissier F; Cavard C; Groussin L; Perlemoine K; Fumey G; Hagneré AM; René-Corail F; Jullian E; Gicquel C; Bertagna X; Vacher-Lavenu MC; Perret C; Bertherat J
    Cancer Res; 2005 Sep; 65(17):7622-7. PubMed ID: 16140927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
    Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
    Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular markers and the pathogenesis of adrenocortical cancer.
    Soon PS; McDonald KL; Robinson BG; Sidhu SB
    Oncologist; 2008 May; 13(5):548-61. PubMed ID: 18515740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatic TP53 mutations are relatively rare among adrenocortical cancers with the frequent 17p13 loss of heterozygosity.
    Libè R; Groussin L; Tissier F; Elie C; René-Corail F; Fratticci A; Jullian E; Beck-Peccoz P; Bertagna X; Gicquel C; Bertherat J
    Clin Cancer Res; 2007 Feb; 13(3):844-50. PubMed ID: 17289876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of adrenocortical cancer.
    Bertherat J; Bertagna X
    Best Pract Res Clin Endocrinol Metab; 2009 Apr; 23(2):261-71. PubMed ID: 19500768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic aspects of adrenocortical tumours and hyperplasias.
    Mazzuco TL; Durand J; Chapman A; Crespigio J; Bourdeau I
    Clin Endocrinol (Oxf); 2012 Jul; 77(1):1-10. PubMed ID: 22471738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of adrenocortical tumours, from familial to sporadic diseases.
    Libé R; Bertherat J
    Eur J Endocrinol; 2005 Oct; 153(4):477-87. PubMed ID: 16189167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis of adrenocortical cancer].
    Szabó D; Zsippai A; Bendes M; Tömböl Z; Szabó PM; Rácz K; Igaz P
    Orv Hetil; 2010 Jul; 151(29):1163-70. PubMed ID: 20591784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenocortical cancer: pathophysiology and clinical management.
    Libè R; Fratticci A; Bertherat J
    Endocr Relat Cancer; 2007 Mar; 14(1):13-28. PubMed ID: 17395972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-like growth factor system on adrenocortical tumorigenesis.
    Ribeiro TC; Latronico AC
    Mol Cell Endocrinol; 2012 Mar; 351(1):96-100. PubMed ID: 22019903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
    Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The genetics of adrenocortical tumors.
    Espiard S; Bertherat J
    Endocrinol Metab Clin North Am; 2015 Jun; 44(2):311-34. PubMed ID: 26038203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations in adrenocortical tumors.
    Reincke M
    Horm Metab Res; 1998; 30(6-7):447-55. PubMed ID: 9694578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular pathogenesis of childhood adrenocortical tumors.
    Almeida MQ; Latronico AC
    Horm Metab Res; 2007 Jun; 39(6):461-6. PubMed ID: 17578765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adrenal cortical tumors and multiple endocrine neoplasia-related syndromes.
    Haase M; Willenberg HS
    Minerva Endocrinol; 2009 Jun; 34(2):123-35. PubMed ID: 19471237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
    Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
    Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.